How Does GoodRx Make Money?
HSChange Editorial Team
Health Policy Research Team, Consumer Health Guidance
Reviewed by Dr. Sarah Mitchell, MD, MPH, Board-Certified Internal Medicine
Last updated: April 4, 2026
GoodRx is free for consumers. You search for your drug, get a coupon, show it at the pharmacy, and pay a discounted price. No subscription required (though they offer one). So where does the money come from? GoodRx pulled in $797 million in revenue in 2025. Here's how.
The Core Business: PBM Fees
GoodRx negotiates discounted drug prices through pharmacy benefit managers (PBMs). When you fill a prescription using a GoodRx coupon, the PBM processes the transaction and pays GoodRx a per-transaction fee. This is GoodRx's largest revenue stream, accounting for roughly $578 million in 2024. The pharmacy accepts the discounted price because the PBM guarantees payment. You pay less than the retail price. GoodRx gets a cut.
GoodRx Gold Subscriptions
GoodRx Gold is a paid subscription that offers deeper discounts than the free coupons. It costs about $6 to $10 per month depending on the plan. Subscribers saved an average of 88% off retail prices in 2024, compared to 83% for free users. For people who fill multiple prescriptions monthly, the subscription can pay for itself quickly.
Pharma Manufacturer Solutions
GoodRx's fastest-growing segment connects pharmaceutical companies directly to consumers through the platform. Drug makers pay GoodRx to promote savings programs, copay cards, and patient assistance offers. This segment grew over 40% year-over-year in 2025. It's essentially advertising, but for prescription drug deals rather than consumer products.
Telehealth Services
GoodRx Care offers telehealth visits starting at $19 with a Gold membership or $49 without. They also launched a weight loss telemedicine subscription. These services generate revenue directly from consumers and add another channel for prescription transactions.
The Privacy Issue
In 2023, the FTC barred GoodRx from sharing consumers' health information for advertising purposes. GoodRx had been sharing prescription data and health conditions with Facebook, Google, and other ad platforms since at least 2017. They paid a $1.5 million FTC penalty and a $25 million class action settlement. GoodRx also displayed a fake HIPAA compliance seal on its telehealth site. These practices have stopped under the FTC order, but they're worth knowing about when considering how the company makes money from your data.